← back to search

Yu‐Ning Wong

Philadelphia VA Medical Center · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Renal cell carcinoma treatment, Economic and Financial Impacts of Cancer, and Prostate Cancer Treatment and Research.
h-index
42
citations
7,216
works
187
NIH funding
primary concept
email

Recent publications

Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer
JCO Clinical Cancer Informatics 2023cited by 9position: middledoi
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System
JAMA Network Open 2022cited by 109position: middledoi
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
European Urology 2016cited by 66position: middledoi
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle‐invasive bladder cancer
Cancer 2015cited by 194position: middledoi
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
Medical Care 2013cited by 712position: middledoi
A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma
British Journal of Urology 2013cited by 35position: middledoi
The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer
The Oncologist 2012cited by 134position: middledoi
Time to Adjuvant Chemotherapy for Breast Cancer in National Comprehensive Cancer Network Institutions
JNCI Journal of the National Cancer Institute 2012cited by 129position: middledoi
Time to diagnosis and breast cancer stage by race/ethnicity
Breast Cancer Research and Treatment 2012cited by 92position: middledoi
Abstract PR06: Racial/ethnic differences in breast cancer survival and mediating effects of tumor characteristics, sociodemographic, and treatment factors.
Cancer Epidemiology Biomarkers & Prevention 2012cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Richard L. Theriault · The University of Texas MD Anderson Cancer Center4 papers (2012–2012)Stephen B. Edge · Roswell Park Comprehensive Cancer Center4 papers (2012–2012)Joyce C. Niland · City of Hope4 papers (2012–2012)Jane C. Weeks · King Edward Memorial Hospital4 papers (2012–2012)Melissa E. Hughes · Yale Cancer Center3 papers (2012–2012)Ann H. Partridge · Harvard University3 papers (2012–2012)Rulla M. Tamimi · Cornell University3 papers (2012–2012) · 3 papers (2012–2012)Douglas W. Blayney · University of Alabama at Birmingham3 papers (2012–2012)Eric P. Winer · Yale University3 papers (2012–2012)Cristina Díaz-Agero Pérez · Universidad Internacional De La Rioja2 papers (2022–2023)Matthew D. Galsky · Rutgers New Jersey Medical School2 papers (2013–2015)Erica T. Warner · Harvard University2 papers (2012–2012)Tori Anglin-Foote · VA Salt Lake City Healthcare System2 papers (2022–2023)Scott L. DuVall · University of Utah2 papers (2022–2023)Julie A. Lynch · University of Utah2 papers (2022–2023)Joaquim Bellmunt · Dana-Farber/Harvard Cancer Center2 papers (2013–2015)Patrick R. Alba · George E. Wahlen Department of VA Medical Center2 papers (2022–2023)Andrea Necchi · Second Foundation (United States)2 papers (2013–2015)Kyung Min Lee · George Mason University2 papers (2022–2023)